BBNX vs BEN · rev $100.3M vs P/E 36, rev $8.77B
Beta Bionics, Inc. Common Stock (BBNX) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
BBNX currently screens at market cap $640.8M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the BBNX and BEN stock pages for the full models.
Not investment advice.